Norway· NO-ID_57F6C708-1468-4905-AFA0-3FA6C7DE24FB

Eskazole

A albendazole product containing albendazole, registered in Norway by GlaxoSmithKline. The same ATC class is registered in 10 of our 19 countries.

ATC P02CA03

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedEskazoleATCP02CA03REGISTER NO.NO-ID_57F6C708-1468-4…PACKS LISTED4CHECKEDOctober 2, 2026

Where it is registered

Albendazole is registered in 10 of 19 countries.

Countries holding a registration under ATC P02CA03 (albendazole), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 6 of them publish a price we can compare per daily dose

Albendazole · ATC P02CA03

10 / 19 countries

  • Czechiaprice
  • Franceprice
  • Germany
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of albendazole costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $5.63 in France to $36.54 in Switzerland — a ×6.5 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Albendazole · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$36.54
  • FR France$5.63
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Albendazole
Manufacturer
GlaxoSmithKline
Country
Norway (NO)
ATC code
P02CA03
ATC class
Albendazole
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
October 2, 2026

Packs & prices · 4

  • no_merkevare_id
    ID_57F6C708-1468-4905-AFA0-3FA6C7DE24FB
  • no_varenummer
    339702
    12
  • no_varenummer
    326281
    60
  • gtin
    8716071001496

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

114 interactions on record for albendazole.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Albendazole · interactions on record

114 records

  • 3 severe
  • 102 moderate
  • 9 minor

Most severe, free to view

  • CladribineL01BB04severe
  • CladribineL04AA40severe
  • ClozapineN05AH02severe
  • AprepitantA04AD12moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Albendazole in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All albendazole products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Eskazole
  • Bulgaria · Зентел
  • Cyprus · Zestaval
  • Germany · Albendazol Micro Labs, Eskazole
  • Spain · Eskazole
  • France · Eskazole, Zentel
  • United Kingdom (Northern Ireland) · Albendazole Brown & Burk Uk
  • Greece · Albendol
  • Hungary · Albendazol Pharma Vim
  • Italy · Zentel
  • Luxembourg · Albendazol Micro Labs
  • Malta · Zestaval
  • Netherlands · Eskazole
  • Poland · Zentel
  • Portugal · Zentel
  • Romania · Albendazol Vim Spectrum, Duador
  • Slovakia · Zentel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/99dac611-476e-407b-88e2-f35261794c40
GET /v1/drugs/99dac611-476e-407b-88e2-f35261794c40?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Albendazol",
  "merkevare_id": "ID_57F6C708-1468-4905-AFA0-3FA6C7DE24FB",
  "name_form_strength": "Eskazole tab 400 mg",
  "prescription_group": "C"
}

See everything about albendazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.